| |
| |
|
| Insider
Information: |
Lewis Joel |
| Relationship: |
|
| City: |
Norcross |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
897,012 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$2,412,962 |
|
|
|
Indirect Value
|
$5,380 |
|
|
| Total
Shares |
899,012 |
|
|
| Total
Value |
$2,418,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 8.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-09-29 |
4 |
A |
$1.92 |
$19,267 |
D/D |
10,035 |
979,440 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-10-13 |
4/A |
A |
$2.01 |
$19,266 |
D/D |
9,585 |
989,025 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-10-13 |
4 |
A |
$2.01 |
$20,170 |
D/D |
10,035 |
989,025 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-10-31 |
4 |
A |
$2.04 |
$19,266 |
D/D |
9,444 |
998,469 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-11-15 |
4 |
A |
$1.87 |
$19,267 |
D/D |
10,303 |
1,008,772 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-11-30 |
4 |
A |
$1.95 |
$19,266 |
D/D |
9,880 |
1,018,652 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-12-15 |
4 |
A |
$1.60 |
$19,267 |
D/D |
12,042 |
1,030,694 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-12-29 |
4 |
A |
$1.66 |
$19,266 |
D/D |
11,606 |
1,042,300 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2024-03-01 |
4 |
A |
$1.96 |
$299,065 |
D/D |
152,584 |
897,716 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-06-25 |
4 |
B |
$7.06 |
$7,058 |
D/D |
1,000 |
51,480 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-01-29 |
4 |
B |
$4.81 |
$4,805 |
D/D |
1,000 |
64,133 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-07 |
4 |
B |
$4.48 |
$4,484 |
D/D |
1,000 |
65,133 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-04-05 |
4 |
B |
$4.82 |
$3,214 |
D/D |
667 |
65,800 |
2.31 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-05-31 |
4 |
B |
$4.28 |
$54,994 |
D/D |
12,849 |
78,649 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-16 |
4 |
B |
$1.52 |
$1,520 |
I/I |
1,000 |
1,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2024-04-24 |
4 |
B |
$3.39 |
$3,390 |
I/I |
1,000 |
2,000 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-03-01 |
4 |
D |
$2.07 |
$156,345 |
D/D |
(75,529) |
820,299 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2020-02-09 |
4 |
OE |
$2.39 |
$19,120 |
D/D |
8,000 |
107,104 |
0 |
- |
|
93 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
